Randomised Controlled Trial of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease: A Pilot Study
Phase of Trial: Phase IV
Latest Information Update: 16 Feb 2010
At a glance
- Drugs Alendronic acid (Primary)
- Indications Arteriosclerosis; Vascular calcification
- Focus Pharmacodynamics
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 22 Sep 2009 Planned end date changed from 1 Dec 2008 to 1 Apr 2009 as reported by ClinicalTrials.gov